Embed Size (px)
Citation preview
Tools to Access the Latest Cancer Tools to Access the Latest Cancer StatisticsStatistics
Paul Miller Washington Reporting Fellowships program presentation
April 15, 2013
SEER area, funded by NCI
SEER/NPCR* area, funded by NCI and CDC
NPCR area, funded by CDC*NPCR – National Program of Cancer Registries
Surveillance, Epidemiology, and End Results (SEER) Surveillance, Epidemiology, and End Results (SEER) Program: Cancer Registries and CollaboratorsProgram: Cancer Registries and Collaborators
The SEER ProgramThe SEER Program SEER collects data on cancer incidence and survival, calculates
prevalence, and compiles these statistics, plus also reports mortality data.
NCI’s Surveillance Research Program (SRP) reports data collected by SEER in the Cancer Statistics Review and other publications made available to reporters and the public. It is usually updated every April 15. This year’s update will cover the period from 1975-2010
Data is also available through SEER tools and resources, such as SEER*Stat software and linked data files. Requests are hand-processed.
Annual Report to the Nation Annual Report to the Nation on the Status of Canceron the Status of Cancer
• NCI partners on the “The Annual Report to the Nation on the Status of Cancer” with CDC, the American Cancer Society, and the North American Association of Central Cancer Registries.
• The most recent Annual Report to the Nation appeared in JNCI on Jan. 7, 2013, with a special section on Human Papilloma Virus (HPV) surveillance.
• The next Annual Report, covering the time period 1975-2010, should appear early in 2014.
SEER Cancer Stat Fact SheetSEER Cancer Stat Fact Sheet
Cancer Stat Fact Sheets provide statistical summaries for 30 cancer sites,
including for “All Cancer Sites.”
seer.cancer.gov/statfacts/
Cancer Stat Fact Sheet: All Cancer SitesCancer Stat Fact Sheet: All Cancer Sites
For each fact sheet, statistics may include Incidence & Mortality, Survival, Lifetime Risk, and Prevalence.
These are updated annually to coincide with SEER data release.
Cancer Stat Fact Sheet: All Cancer SitesCancer Stat Fact Sheet: All Cancer SitesSEER IncidenceSEER Incidence
SEER IncidenceSEER Incidence Incidence is the number of new cases of disease diagnosed each year.
The “age-adjusted” incidence rate for All Cancer Sites was 465.2 per 100,000 people per year. This is based on cases diagnosed in 2005-2009 from 18 SEER geographic areas.
Cancer Stat Fact Sheet: All Cancer SitesCancer Stat Fact Sheet: All Cancer SitesUS MortalityUS Mortality
US MortalityUS Mortality US mortality is the number of deaths in a certain group of people in a certain period of time.
The “age-adjusted” death rate for All Cancer Sites was 178.7 per 100,000 people per year.
This rate is based on patients who died in 2005- 2009 in the United States.
Cancer Stat Fact Sheet: All Cancer SitesCancer Stat Fact Sheet: All Cancer SitesTrends in RatesTrends in Rates
Trends in SEER Incidence RatesTrends in SEER Incidence Rates Trends can be evaluated by the annual percent change (APC).
From 1998 to 2009 the APC for All Cancer Sites was -0.5. This was a statistically significant decrease. Joinpoint analyses are used to evaluate when changes in the trend occurred with the APC.
Joinpoint Trends in SEER Incidence Rates, 1975-2009Joinpoint Trends in SEER Incidence Rates, 1975-2009All Cancer SitesAll Cancer Sites
300
350
400
450
500
550
1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009
Rat
e p
er 1
00,0
00
Year
~~
0
1975-19891.2*
1989-19922.8
1992-1995-2.5
1995-19981.2
1998-2009-0.5*
Joinpoint Trend in SEER Cancer IncidenceJoinpoint Trend in SEER Cancer Incidence An asterisk after the APC indicates that the trend was statistically significant.
Negative estimate indicates that cancer incidence was decreasing in that time period.
Cancer Stat Fact Sheet: All Cancer SitesCancer Stat Fact Sheet: All Cancer SitesSurvivalSurvival
SurvivalSurvivalThese survival statistics are based on 5-year Relative Survival. Relative survival estimates the percentage of patients expected to survive their cancer at a least 5 years after diagnosis.
The overall 5-year relative survival rate for men and women was 65.4%.
This is based on cases diagnosed between 2002-2008 from 18 SEER geographic areas.
Cancer Stat Fact Sheet: All Cancer SitesCancer Stat Fact Sheet: All Cancer SitesLifetime RiskLifetime Risk
Lifetime RiskLifetime Risk Lifetime Risk is an estimate of the percentage of patients who will be diagnosed with cancer in their lifetime.
Based on rates from 2007-2009, 41.2% of men and women born today will be diagnosed with cancer in their lifetime.
SEER also calculates the probability of developing cancer between two age groups. This is available in Fast Stats.
Cancer Stat Fact Sheet: All Cancer SitesCancer Stat Fact Sheet: All Cancer SitesPrevalencePrevalence
PrevalencePrevalence Prevalence is the number of people alive that have had a previous diagnosis of cancer.
On January 1, 2009, there were 12,553,337 men and women alive who had a history of cancer of all sites.
Trends in SEER Incidence by Trends in SEER Incidence by Primary Cancer Site, 2000-2009Primary Cancer Site, 2000-2009
Average Annual Percent Change 2000-2009
MyelomaBrain & Other Nervous SystemLung & Bronchus (Female)Urinary BladderAll Sites Except Lung & BronchusAll Cancer SitesBreast (Female)EsophagusLeukemiaStomachOvaryCervix UteriProstateLung & Bronchus (Male)LarynxColon & Rectum
ThyroidLiver & Intrahepatic Bile Duct
Kidney & Renal PelvisMelanoma of the Skin
PancreasCorpus & Uterus, NOS
Hodgkin LymphomaTestis
Non-Hodgkin LymphomaOral Cavity & Pharynx
* The APC is significantly different from zero (p<.05)
Trends in US Death Rates by Trends in US Death Rates by Primary Cancer Site, 2000-2009Primary Cancer Site, 2000-2009
Average Annual Percent Change 2000-2009
Esophagus
Brain & Other Nervous System Testis Lung & Bronchus (Female) Kidney & Renal Pelvis Leukemia Oral Cavity & Pharynx All Cancer Sites
All Sites Except Lung & Bronchus Ovary Cervix Uteri Myeloma Breast (Female) Hodgkin Lymphoma Lung & Bronchus (Male) Larynx Colon & Rectum
Non-Hodgkin Lymphoma Stomach Prostate
Liver & Intrahepatic Bile Duct
Thyroid Melanoma of the Skin
Pancreas Corpus & Uterus, NOS
Urinary Bladder
* The APC is significantly different from zero (p<.05)
SEER Web SitesSEER Web Sites• SEER Home Page (http://seer.cancer.gov/)
• Cancer Statistics (http://seer.cancer.gov/statistics/)– Fact Sheets– Cancer Statistics Review (CSR)– State Cancer Profiles
• Access to SEER Datasets and NCI Software to analyze data (http://seer.cancer.gov/resources/)
What is State Cancer Profiles?
Statistics for prioritizing
cancer control activities National, state, and local level data Collaboration
CDC’s National Program of Cancer Registries (NPCR)
NCI’s Surveillance, Epidemiology and End Results Registries (SEER)
Available Data
Cancer incidence, mortality data and prevalence data
Latest data years currently available 2009 NCI SEER incidence (2010 coming
soon) 2009 CDC NPCR incidence 2009 NCHS mortality
About 20 different cancer sitesScreening and risk factor data
State Cancer Profiles Usage
Resource for: Priority setting; planning Implementing and assessing cancer control projects Exposing health disparities Comparing state cancer data with other states Reviewing trends in cancer Presentations, reports, proposals, training
Quick Profiles
Support Data
Death Rate/Trend Comparison by Cancer
SCP: Screening and Risk Factors
Mammography by State
Mammography by Small Area Estimates
Demographic Data
Population: Age GroupsPopulation: Race GroupsEducationIncomeHousingUrban/RuralWorkforce: UnemployedPoverty
Persons below Poverty
Coming Soon to State Cancer Profiles
Home Page HINTS (Health Interview National Trends Survey)
Demographic data Small Area Health Insurance Estimates
